Science

CERN’s proposition for a new particle collider, the Future Circular Collider (FCC), brings forth a vision that transcends mere scientific inquiry—it embodies an ambition that some argue is akin to the monumental projects of ancient civilizations. With a projected cost of approximately $17 billion, proponents assert that this mega-scientific undertaking is crucial for maintaining Europe’s
0 Comments
In a groundbreaking development in quantum computing, researchers have harnessed the eerie randomness of entangled qubits to generate numbers that defy predictability. This achievement is significant; it not only challenges our traditional understanding of randomness but also propels quantum technology into the practical realm. If traditional supercomputers represent the pinnacle of classical computational power, this
0 Comments
The astonishing discovery of Duonychus tsogtbaatari, a feathered bipedal dinosaur sporting just two incredibly long fingers, has ignited a fervent debate within the paleontological community. This find, unearthed in the arid expanses of southeastern Mongolia’s Gobi Desert, presents an opportunity to reconsider what we thought we knew about the evolution of theropod hands, and by
0 Comments
As we delve into the complexities of the aging brain, it’s alarming to recognize that our cognitive faculties can deteriorate as crucial cleaning processes falter. The latest findings from Washington University in St. Louis reveal that the meningeal lymphatics—often overlooked vessels surrounding the brain—play a pivotal role in maintaining cognitive function. This begs the question:
0 Comments
For decades, sharks have been portrayed as the silent predators of the deep, overshadowed by mythical depictions that frighten and fascinate in equal measure. Yet, recent groundbreaking research challenges this established narrative by unveiling an extraordinary auditory capability within these mighty creatures. The investigation led by marine scientists at the Woods Hole Oceanographic Institute reveals
0 Comments
In an age where science is supposed to be unbiased and objective, the findings surrounding gender differences in Alzheimer’s disease research reveal a troubling undercurrent of oversight and incompleteness. Recent findings surrounding the drug lecanemab highlight a glaring discrepancy: while it may slow cognitive decline by 27% over an 18-month trial duration, the effects are
0 Comments